In a myasthenia gravis patient with edrophonium challenge, if tidal volume decreases after administration, what is the most appropriate management step?

In a myasthenia gravis patient with edrophonium challenge, if tidal volume decreases after administration, what is the most appropriate management step?

• A. Tracheal intubation and mechanical ventilation
• B. Repeat the test dose of edrophonium
• C. Administer neostigmine 1 mg IV
• D. Administer atropine 0.4 mg IV

Answer: (A)

When edrophonium is given during testing in a myasthenia gravis patient, a rise in acetylcholine can either improve weakness or, if a cholinergic crisis is present, worsen it. A drop in tidal volume after administration indicates worsening respiratory muscle weakness due to excess acetylcholine—a sign of cholinergic crisis and potential respiratory failure. The immediate, life-saving step is to secure the airway with tracheal intubation and provide mechanical ventilation to support ventilation while the crisis is managed. After stabilization, you would address muscarinic effects (e.g., with atropine) and discontinue the acetylcholinesterase inhibitor as appropriate; repeating the test or giving more acetylcholine would only worsen the situation.

When edrophonium is given during testing in a myasthenia gravis patient, a rise in acetylcholine can either improve weakness or, if a cholinergic crisis is present, worsen it. A drop in tidal volume after administration indicates worsening respiratory muscle weakness due to excess acetylcholine—a sign of cholinergic crisis and potential respiratory failure. The immediate, life-saving step is to secure the airway with tracheal intubation and provide mechanical ventilation to support ventilation while the crisis is managed. After stabilization, you would address muscarinic effects (e.g., with atropine) and discontinue the acetylcholinesterase inhibitor as appropriate; repeating the test or giving more acetylcholine would only worsen the situation.